Markets:

Overview

News

Currencies

International

Treasuries

Relay Therapeutics, Inc. - Common Stock (NQ:RLAY)

8.930 +0.120 (+1.36%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Relay Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

AI-Focused Drug Discovery Stocks Index Up 10.6% Last Week ↗

December 17, 2023

A new study concludes that the AI method of drug discovery is up to 250 times more efficient than the traditional method.

Via Talk Markets

Topics Artificial Intelligence

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 13, 2023

Via Benzinga

HC Wainwright & Co. Maintains Buy Rating for Relay Therapeutics: Here's What You Need To Know ↗

December 11, 2023

Via Benzinga

The 10 Stocks Using AI To Develop New Drugs Were Up 4%, On Average, Last Week ↗

December 11, 2023

If, as Morgan Stanley postulates, a $50 billion AI drug discovery revolution is underway, here are 10 publicly-traded micro- and small-cap clinical stage pharma companies that are embracing AI to...

Via Talk Markets

Topics Artificial Intelligence

Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November ↗

December 06, 2023

The AI method is up to 250 times more efficient than the traditional method of drug discovery. reducing timelines for drug discovery, increasing accuracy of efficacy and safety predictions.

Via Talk Markets

Topics Artificial Intelligence

Relay Therapeutics's Earnings Outlook ↗

November 01, 2023

Via Benzinga

Earnings Outlook For Relay Therapeutics ↗

August 07, 2023

Via Benzinga

11 Analysts Have This to Say About Relay Therapeutics ↗

June 09, 2023

Via Benzinga

Relay Therapeutics: Q1 Earnings Insights ↗

May 04, 2023

Via Benzinga

AI Alert: 3 Healthcare Stocks That Are Investing in Artificial Intelligence ↗

November 09, 2023

We’re still in the initial stages of a massively disruptive artificial intelligence (AI) boom that's greatly impacting healthcare.

Via InvestorPlace

Topics Artificial Intelligence

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 12, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

September 19, 2023

During Tuesday's session, 275 companies made new 52-week lows.

Via Benzinga

Earnings Outlook For Relay Therapeutics ↗

May 03, 2023

Via Benzinga

Earnings Scheduled For November 2, 2023 ↗

November 02, 2023

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.

Via Benzinga

What 11 Analyst Ratings Have To Say About Relay Therapeutics ↗

April 20, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

September 26, 2023

On Tuesday, 386 stocks made new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

September 07, 2023

On Thursday, 283 companies set new 52-week lows.

Via Benzinga

InMode, Daktronics, Domino's Pizza And Other Big Stocks Moving Higher On Wednesday ↗

July 12, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Looking To Invest In Artificial Intelligence? Consider Evogene And Its Five Subsidiaries ↗

April 27, 2023

Evogene employs an artificial intelligence platform for decoding plant phenotypes and microbial genomes. Consider its' research agenda, applications, and at-the-market products. The set-up may present...

Via Talk Markets

Why Relay Therapeutics Stock Is Trading Higher Today ↗

April 19, 2023

Relay Therapeutics (NASDAQ: RLAY) shares are trading higher after Raymond James upgraded the stock from Outperform to Strong Buy and announced a $29 price target. Also, the stock is rebounding...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 18, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2023 ↗

April 20, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

April 18, 2023

On Tuesday, 91 stocks hit new 52-week lows.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 19, 2023 ↗

April 19, 2023

Via Benzinga

Why Relay Therapeutics Stock Is Plunging Today ↗

April 18, 2023

Relay Therapeutics Inc (NASDAQ: RLAY) announced initial clinical data for RLY-2608, an investigational allosteric, pan-mutant, and isoform-selective inhibitor of PI3Kα.

Via Benzinga

Ericsson, Johnson & Johnson, Goldman Sachs And Other Big Stocks Moving Lower On Tuesday ↗

April 18, 2023

U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 18, 2023

Gainers Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional...

Via Benzinga

Relay Therapeutics' Stock Price Premium Vs Peers Is Justified By Its Platform Technology, Analyst Says ↗

April 13, 2023

Via Benzinga

Get In Now. 7 Stocks That Are Set to Soar. ↗

April 13, 2023

While it’s always difficult to determine which stocks to buy might break out imminently, speculators should watch these ideas.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2023 ↗

April 13, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Relay Therapeutics, Inc. - Common Stock (NQ:RLAY)

Headline News about Relay Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today